• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, April 21, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Cure Brain Cancer supports brain cancer immunotherapy trials

Bioengineer by Bioengineer
November 21, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Walter and Eliza Hall Institute, Australia

Our research into new treatments for brain cancer has been boosted by fellowship funding from Cure Brain Cancer Foundation.

A three-year fellowship will support Dr Ryan Cross to translate his research into harnessing immune cells to fight brain cancer, a field known as 'cancer immunotherapy'.

Brain cancer: a deadly disease

More than 1600 new cases of brain cancer are diagnosed in Australia each year. Brain cancer is the leading cause of cancer-related deaths in adults under 40. Cancer can originate in many different cell types in the brain, giving rise to various forms of brain cancer.

Dr Cross said brain cancer also caused more deaths in Australian children than any other disease.

"In the past 30 years patient survival hasn't improved for either adults or children with aggressive brain cancer, despite dramatic improvements in treatments for many other cancers," Dr Cross said.

Improving brain cancer treatments

Dr Ryan Cross has received a Cure Brain Cancer Foundation Early Career Fellowship of $345,000 over three years to fund his research.

Dr Cross, who works with Institute laboratory head Dr Misty Jenkins, said his research focused on two of the deadliest types of brain cancer, diffuse intrinsic pontine glioma (DIPG) – the most aggressive form of brain cancer in children – and adult glioblastoma.

"This work will use patient samples to discover how best to program cancer-fighting immune T cells in the lab to kill brain cancer. This fellowship will enable me to test and refine this approach, developing a 'pipeline' that could allow personalised treatments for children and adults with brain cancer," Dr Cross said.

"An exciting aspect of this work is that everything we do is aiming to initiate clinical trials, which will test whether the cancer-fighting immune T cells we generate are an effective treatment for brain cancer when given to patients."

Collaborative research

Dr Cross said his research was made possible by partnerships with industry, as well as with other scientific and clinical organisations within the Victorian Comprehensive Cancer Centre.

"This work was initiated using seed funding that I received from The Jack Brockhoff Foundation, and now Cure Brain Cancer Foundation have provided me with vital support to continue my research to try and help children with brain cancer."

"I would also like to acknowledge the valuable input we have had from Dr Robert de Rose, a research consumer with personal experience of caring for someone with brain cancer," Dr Cross said.

###

Media Contact

Vanessa Solomon
[email protected]
61-475-751-811
@WEHI_research

Home

Original Source

https://www.wehi.edu.au/news/cure-brain-cancer-supports-brain-cancer-immunotherapy-trials

Share14Tweet8Share2ShareShareShare2

Related Posts

Single-Cell Epigenomes Link Fat to Heart Disease Risk

April 21, 2026

Follow-Up Results from Pioneering Bowel Cancer Trial Reveal Zero Relapses

April 21, 2026

Smartphone Video Enhances Parkinson’s DBS Programming

April 20, 2026

Lab-Grown Mini Brain Models Offer New Hope for Diagnosing and Treating Alzheimer’s Disease

April 20, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    504 shares
    Share 202 Tweet 126
  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    64 shares
    Share 26 Tweet 16
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    101 shares
    Share 40 Tweet 25
  • Boosting Breast Cancer Risk Prediction with Genetics

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Single-Cell Epigenomes Link Fat to Heart Disease Risk

Follow-Up Results from Pioneering Bowel Cancer Trial Reveal Zero Relapses

Smartphone Video Enhances Parkinson’s DBS Programming

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 79 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.